China, Aug. 19 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical study on the inhibitory effect of rapamycin nanoemulsion on proliferative vitreoretinopathy'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130279
Registration Time: 2026/08/18
Type: Interventional study
Primary Sponsor: Tianjin Medical University General Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=328590
Published by HT Digital Content Services with permission from Health Daily Digest....